Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q2 2023 Earnings Call Transcript August 8, 2023
Ironwood Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.31, expectations were $0.25.
Operator: Ladies and gentlemen, thank you for standing by. My name is Sharell and I will be your conference operator today. At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals Q2 2023 Investor Update Conference Call. [Operator Instructions]. I would now like to turn...
